The role of fPSA, [-2]proPSA and the Prostate Health Index for the early prediction of outcome in patients with metastatic castration resistant prostate cancer on therapy with abirateroneacetate.
Schlack K, Krabbe LM, Eminaga O, Semjonow A, Boegemann M
Abstract in digital collection (conference) | Peer reviewedDetails about the publication
Status: Published
Release year: 2016
Language in which the publication is written: English
Conference: ASCO-GU, San Francisco, undefined
Authors from the University of Münster
| Bögemann, Martin | Clinic for Urology |
| Schlack, Katrin | Clinic for Urology |
| Semjonow, Axel | Clinic for Urology |